SITC gratefully acknowledges the following supporters of the society's 36th Annual Meeting & Pre-Conference Programs.
36th Annual Meeting
Platinum
AstraZeneca Pharmaceuticals LP
Bristol Myers Squibb
Incyte Corporation
Silver
Alkermes, Inc.
Exelixis, Inc.
Exelixis, Inc. - Commercial
Janssen Pharmaceuticals Research & Development, LLC
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.
Regeneron Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Bronze
Agenus, Inc.
Gamida Cell
IsoPlexis
NanoString Technologies (The CheckPoints Party)
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
Copper
7 Hills Pharma, LLC (The CheckPoints Party)
Fluidigm Corporation (The CheckPoints Party)
Nektar Therapeutics (The CheckPoints Party)
Primer on Tumor Immunology and Cancer Immunotherapy™
Silver
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.
Bronze
Genentech, Inc.
Novartis Pharmaceuticals CorporationPfizer, Inc.
Immuno-Resistance and Sequencing Symposium
Silver
AstraZeneca Pharmaceuticals LP
Bristol Myers Squibb
Merck Sharp & Dohme, Corp., a subsidiary of Merck & Co., Inc.
Bronze
Alkermes, Inc.
Pfizer, Inc.
Regeneron Pharmaceuticals
Copper
Genentech, Inc.
The Evolution of Immunotherapy: An Exploration of Immunity Beyond T cells, CAR T in Solid Tumors and Novel Combinations
Gold
Bristol Myers Squibb
Bronze
Genentech, Inc.
World Immunotherapy Council's 4th Young Investigator Symposium
Silver
Bristol Myers Squibb
Bronze
Merck & Co., Inc.
Copper
Pfizer, Inc.
Supporters as of Nov. 1, 2021